2 unknown, 1 not yet recruiting. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Unknown 2, Not yet recruiting 1 |
Follow Chen Xiangmei: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Naoxintong Capsule for Diabetic Nephropathy With Dampness Retention Pattern: A Multicenter, Randomized, Double-Blind, Placebo-Controlled TrialAcronymNXT-DKD Naoxintong Capsule, Placebo - Diabetic Nephropathy | Phase 4 | Not yet recruiting | Chen Xiangmei | 410 | 2027-03-01 | 2026-07-13 |
| Safety and Efficacy of Shenyankangfu Tablets for Chronic Kidney Disease Shenyan Kangfu Tablet - Chronic Kidney Disease | Phase 4 | Unknown | Chen Xiangmei | 1500 | 2015-06-01 | 2016-09-01 |
| Efficacy and Safety of Abelmoschus Manihot for IgA Nephropathy Losartan, Abelmoschus manihot - IgA Nephropathy | Phase 4 | Unknown | Chen Xiangmei | 1600 | 2014-09-01 | 2016-07-06 |
Diabetic Nephropathies (1) · Glomerulonephritis, IGA (1) · Proteinuria (1) · Renal Insufficiency, Chronic (1)
Huangkui (1) · Losartan (1) · naoxintong (1) · shenyan kangfu (1)
China (3)
HongTao Yang, investigator (1) · Jie Wu, investigator (1) · LiQun Song, investigator (1) · Lu Ma, investigator (1) · Meng Liang, investigator (1) · Ping Luo, investigator (1) · QiaoLing Zhou, investigator (1) · RongShan Li, investigator (1) · Xiangmei Chen, MD.& Ph.D (1) · XiaoHong Cheng, investigator (1) · YongLi Zhan, investigator (1)